Published: Feb, 2018

The global microfluidics market has been envisioned in a report by Transparency Market Research (TMR) to mark the presence of a number of internationally recognized companies, leaving the competitive landscape highly consolidated. Thermo Fisher Scientific, F. Hoffman-La Roche AG, and Danaher Corporation are the three leading companies that attained a maximum share of 53.0% in 2016. They could look to continue with their dominance in the market by strengthening their regional presence and widening their product portfolios. In this regard, you also could see other companies focusing on the launch of technologically developed offerings to cater to various applications including medical diagnostics, therapeutic devices, and drug discovery.

TMR has prognosticated the global microfluidics market to rise at an 11.4% CAGR between 2017 and 2025. By 2025, the market could be valued at a US$12.45 bn. In 2016, it gained a valuation of US$4.76 bn. In terms of product, the market has been expected to crown cartridges and reagents as a leading segment anticipated to expand at a 12.2% CAGR. By geography, the market could witness the lead secured by North America considering its larger revenue of US$1.7 bn earned in 2016.

microfluidics market

Sales of Microfluidics Platforms Stem from Demand for Cost-effective Diagnostic Procedures

The demand for cost-efficient diagnostic procedures that require small-sized medical equipment and involve budget usage of reagents has been foreseen to stimulate the sales of microfluidics platforms. Analysts have observed the market to testify of the advent of several product innovations including inexpensive point-of-care testing, which could help companies to obtain a strong share in the near future. Thus, the rising demand for economical microfluidics to be used in point-of-care settings has been predicted to be a significant factor augmenting market growth.

Especially in developing countries of Asia Pacific, you could see clinicians and patients alike being incalculably benefited with the introduction of cheap point-of-care diagnostics receiving support from microfluidics technologies. As the incidence of chronic diseases such as cancer, diabetes, and cardiovascular continues to surge, the requirement of low-cost point-of-care diagnostics has been projected to increase simultaneously, promising the world microfluidics market a continuous boost in growth.

Longer Approval of Microfluidics Adversely Affects Market Earnings

The extortionate cost of instruments has been prophesied to threaten the demand for microfluidics in the coming years. Furthermore, prolonged approval procedures of notable agencies such as the FDA could have a negative impact on the market.

However, besides the launch of inexpensive microfluidics for point-of-care testing, increasing research and development in the field has been foretold to create scores of opportunities in the foreseeable future. Most research and development activities could be assigned for the discovery of innovative drug delivery methods. The growth of the international microfluidics market has been envisaged to be further improved with several leading companies stepping into collaborations. Manufacturers have also been observed to use polymers for reducing the manufacturing cost of advanced microfluidics.

The information presented in this review is based on a TMR report, titled “Microfluidics Market (Product - Instruments, Microfluidic Chips, and Cartridges and Reagents; Application - Peripheral Vascular Diseases, Wound Care Management, Pharmaceutical and Biotech Research, In vitro Diagnostics, and Drug Delivery; Material - Polymer-based and Glass-based; End User - Hospitals, Academic and Research Institutes, Diagnostic Labs, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.”

Key Takeaways

  • Rising demand for cartridges and reagents in various assays and techniques fetches them higher revenue growth.
  • North America gains from the launch of a wide range of novel technologies for point-of-care testing methods.

The global microfluidics market has been segmented as presented below:

Global Microfluidics Market by Product

  • Microfluidic Chips
  • Instruments
  • Cartridges and Reagents

Global Microfluidics Market by Application

  • Peripheral Vascular Diseases
  • Wound Care Management
  • Pharmaceutical and Biotech Research
  • In vitro Diagnostics
  • Drug Delivery

Global Microfluidics Market by Material

  • Polymer-based
  • Glass-based

Global Microfluidics Market by End User

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic Labs
  • Homecare Settings

Global Microfluidics Market by Geography

  • North America
    • U.S.
    • Canada 
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453